Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

APREPITANT

APREPITANT

Standard Dose
125MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview APREPITANT is listed in Drugs@FDA under application 211835 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient APREPITANT Form and strength CAPSULE;ORAL - 125MG Sponsor TORRENT Submission history Latest submission status date: 2022-08-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview APREPITANT is listed in Drugs@FDA under application 211835 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient APREPITANT Form and strength CAPSULE;ORAL - 125MG Sponsor TORRENT Submission history Latest submission status date: 2022-08-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.